Theratechnologies EBIT margin
Was ist das EBIT margin von Theratechnologies?
EBIT margin von Theratechnologies Inc. ist -54.61%
Was ist die Definition von EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Theratechnologies
Was macht Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Unternehmen mit ebit margin ähnlich Theratechnologies
- Rhino Resource Partners LP hat EBIT margin von -55.35%
- United States Antimony hat EBIT margin von -55.33%
- Diamond Offshore Drilling hat EBIT margin von -55.32%
- Empire Industries hat EBIT margin von -55.10%
- BioHiTech Global Inc hat EBIT margin von -54.78%
- Sientra Inc hat EBIT margin von -54.62%
- Theratechnologies hat EBIT margin von -54.61%
- Toughbuilt Industries Inc hat EBIT margin von -54.24%
- CloudMD Software & Services hat EBIT margin von -53.91%
- The Motor & General Finance hat EBIT margin von -53.90%
- Fulgent Genetics Inc hat EBIT margin von -53.81%
- Cronos Inc hat EBIT margin von -53.80%
- Mukand Engineers hat EBIT margin von -53.56%